platycodin d has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, JY; Lou, Y; Peng, Y; Xiong, J; Zhu, Y | 1 |
| Chun, J; Joo, EJ; Kang, M; Kim, YS | 1 |
2 other study(ies) available for platycodin d and Stomach Neoplasms
| Article | Year |
|---|---|
miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Mice; Mice, Nude; MicroRNAs; Saponins; Stomach Neoplasms; Survivin; Triterpenes; Xenograft Model Antitumor Assays | 2019 |
Platycodin D induces anoikis and caspase-mediated apoptosis via p38 MAPK in AGS human gastric cancer cells.
Topics: Anoikis; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Humans; Imidazoles; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Saponins; Signal Transduction; Stomach Neoplasms; Transcription Factor AP-1; Triterpenes | 2013 |